Dr. Shabbir is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1750 N Randall Rd
Ste 120
Elgin, IL 60123Phone+1 847-608-6647
Education & Training
University of Miami/Jackson Health SystemResidency, Dermatology, 2013 - 2016
University at BuffaloInternship, Internal Medicine, 2011 - 2012- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2011
Certifications & Licensure
IL State Medical License 2016 - 2026
CA State Medical License 2018 - 2025
CT State Medical License 2020 - 2025
IN State Medical License 2021 - 2025
WI State Medical License 2016 - 2025
ME State Medical License 2019 - 2022
WV State Medical License 2018 - 2021- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 3 citationsDupilumab in Adults With Moderate to Severe Atopic Dermatitis: A 5-Year Open-Label Extension Study.Lisa A Beck, Robert Bissonnette, Mette Deleuran, Takeshi Nakahara, Ryszard Galus
JAMA Dermatology. 2024-08-01 - 4 citationsEfficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis: A Post Hoc Analysis of 6 Randomized Clinical Trials.Amy S Paller, Jonathan I Silverberg, Michael J Cork, Emma Guttman-Yassky, Benjamin Lockshin
JAMA Dermatology. 2023-03-01 - 48 citationsDupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.Lisa A Beck, Mette Deleuran, Robert Bissonnette, Marjolein de Bruin-Weller, Ryszard Galus
American Journal of Clinical Dermatology. 2022-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
